BioMarin Pharmaceutical Files Current Report
Ticker: BMRN · Form: 8-K · Filed: Dec 22, 2025 · CIK: 1048477
| Field | Detail |
|---|---|
| Company | Biomarin Pharmaceutical INC (BMRN) |
| Form Type | 8-K |
| Filed Date | Dec 22, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 B |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, current-report, other-events
Related Tickers: BMRN
TL;DR
BioMarin filed a routine 8-K on 12/19/25 for 'Other Events'.
AI Summary
On December 19, 2025, BioMarin Pharmaceutical Inc. filed an 8-K report. The filing indicates that the report is a "Current Report" and is being filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The report's earliest event date is December 19, 2025, and it is categorized under "Other Events."
Why It Matters
This filing signifies a routine update or disclosure from BioMarin Pharmaceutical Inc. to the SEC, providing transparency to investors about company events.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for 'Other Events' and does not appear to contain material non-public information that would immediately impact the stock price.
Key Numbers
- 000-26727 — SEC File Number (Identifies the specific SEC filing for the company.)
- 12 — Public Document Count (Indicates the number of documents included in this filing.)
Key Players & Entities
- BioMarin Pharmaceutical Inc. (company) — Registrant
- December 19, 2025 (date) — Date of earliest event reported
- 1048477 (company) — Central Index Key
- 2834 (industry_code) — Standard Industrial Classification
- 680397820 (tax_id) — I.R.S. Employer Identification No.
- 770 Lindaro Street (address) — Address of Principal Executive Offices
- San Rafael (city) — City of Principal Executive Offices
- California (state) — State of Principal Executive Offices
- 94901 (zip_code) — Zip Code of Principal Executive Offices
- 4155066700 (phone_number) — Registrant's telephone number
FAQ
What specific event triggered this 8-K filing?
The filing is categorized under 'Other Events' and does not specify a particular event in the provided text.
What is the earliest date associated with this report?
The earliest event reported is dated December 19, 2025.
What is BioMarin Pharmaceutical Inc.'s Standard Industrial Classification code?
The SIC code listed is 2834, which corresponds to Pharmaceutical Preparations.
Where are BioMarin Pharmaceutical Inc.'s principal executive offices located?
The principal executive offices are located at 770 Lindaro Street, San Rafael, California, 94901.
What is the purpose of filing a Form 8-K?
A Form 8-K is a report of unscheduled material events or corporate changes that could be of importance to investors.
Filing Stats: 387 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2025-12-22 09:00:13
Key Financial Figures
- $0.001 B — ich registered Common Stock, par value $0.001 BMRN The Nasdaq Global Select Market I
Filing Documents
- d45090d8k.htm (8-K) — 22KB
- 0001193125-25-327828.txt ( ) — 129KB
- bmrn-20251219.xsd (EX-101.SCH) — 3KB
- bmrn-20251219_lab.xml (EX-101.LAB) — 17KB
- bmrn-20251219_pre.xml (EX-101.PRE) — 11KB
- d45090d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. BioMarin Pharmaceutical Inc., a Delaware corporation Date: December 22, 2025 By: /s/ G. Eric Davis G. Eric Davis Executive Vice President, Chief Legal Officer